Literature DB >> 11580886

Qs in the nucleus.

H T Orr1.   

Abstract

The polyglutamine diseases include at least nine neurodegenerative disorders. Accumulation of mutant protein with a toxic gain-in function in the nucleus appears to be the pathological basis of these diseases. In this issue of Neuron, La Spada et al. (2001) provide insight into the cell specificity of pathology for a polyglutamine disease by relating SCA7-induced retinal degeneration to a disruption of the photoreceptor-specific transcription factor CRX.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580886     DOI: 10.1016/s0896-6273(01)00435-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  3 in total

1.  Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2.

Authors:  Edoardo Marcora; Katherine Gowan; Jacqueline E Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

2.  Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.

Authors:  P J S Vig; J Wei; Q Shao; M D Hebert; S H Subramony; L T Sutton
Journal:  Neurosci Lett       Date:  2007-04-05       Impact factor: 3.046

3.  Nucleocytoplasmic shuttling activity of ataxin-3.

Authors:  Sandra Macedo-Ribeiro; Luísa Cortes; Patrícia Maciel; Ana Luísa Carvalho
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.